Last 459.75 GBp
Change Today +2.75 / 0.60%
Volume 317.2K
ABC On Other Exchanges
Symbol
Exchange
London
Berlin
OTC US
OTC US
As of 11:14 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

abcam plc (ABC) Snapshot

Open
457.25 GBp
Previous Close
457.00 GBp
Day High
462.25 GBp
Day Low
453.75 GBp
52 Week High
01/31/14 - 533.50 GBp
52 Week Low
04/8/14 - 346.00 GBp
Market Cap
923.5M
Average Volume 10 Days
541.5K
EPS TTM
0.17 GBp
Shares Outstanding
200.9M
EX-Date
11/6/14
P/E TM
26.9x
Dividend
8.61 GBp
Dividend Yield
1.88%
Current Stock Chart for ABCAM PLC (ABC)

Related News

No related news articles were found.

abcam plc (ABC) Related Businessweek News

No Related Businessweek News Found

abcam plc (ABC) Details

Abcam plc, through its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, tools and reagents, and immunoassays. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, drug discovery products and services, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company sells its products primarily through the Internet. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom.

740 Employees
Last Reported Date: 10/4/14
Founded in 1998

abcam plc (ABC) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: 185.0K GBP
Co-Founder and Deputy Chairman
Total Annual Compensation: 628.0K GBP
Chief Financial Officer, Company Secretary, D...
Total Annual Compensation: 478.0K GBP
Chief Operating Officer, Director and Member ...
Total Annual Compensation: 481.0K GBP
Compensation as of Fiscal Year 2014.

abcam plc (ABC) Key Developments

Abcam plc Appoints Sue Harris as a Non-Executive Director

Abcam plc announced the appointment of Sue Harris as a non-Executive Director on the company's Board. Sue will join the Board with immediate effect and will Chair the Audit Committee. Sue subsequently held senior executive roles at Marks & Spencer, across finance and latterly as Head of Corporate Development, and Standard Life where she led the process to float the company on the London Stock Exchange in 2006. She then joined Lloyds Banking Group (LBG) where she was Finance Director of respectively; Cheltenham and Gloucester; LBG's Retail Bank; and LBG Group Finance; and latterly Group Audit Director. Sue is a Member of the Audit and Assurance Council of the Financial Reporting Council and previously was a Non-Executive Director on the Board of St. James's Place (representing LBG) and a Member of the Audit and Remuneration Committee of the British Bankers' Association. She is Chair of Trustees for KCP Youth and during a ten year association with Mencap chaired both the Finance and Audit Committees.

Peter Keen Ceases to Be Non-Executive Director of ABCAM PLC

The Biotech Growth Trust PLC announced that Mr. Peter Keen, non-executive Director, ceased to be a non-executive Director of ABCAM PLC with effect from November 3, 2014.

Abcam Plc, Annual General Meeting, Nov 03, 2014

Abcam Plc, Annual General Meeting, Nov 03, 2014., at 11:00 GMT Standard Time. Location: 330 Cambridge Science Park. Agenda: To receive and adopt the report of the Directors and the financial statements together with auditor's report for the year ended 30 June 2014; to declare a final dividend; to approve the annual report on remuneration for the year ended 30 June 2014 and accounts for the year ended 30 June 2014; to approve the directors' remuneration policy of the annual report and accounts for the year ended 30 June 2014; to re-appoint PricewaterhouseCoopers LLP as auditor and to authorise the Directors to determine their remuneration; to elect Alan Hirzel as a Director; to elect Louise Patten as a Director; to re-elect Jim Warwick as a Director; to approve the proposed amendment to the Abcam 2005 Share Option Scheme and to authorise the Directors to do all such things as may be necessary to carry the same into effect; to exercise all the powers of the company to allot shares in the company; to allot equity securities; and to make market purchases.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABC:LN 459.75 GBp +2.75

ABC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Affymetrix Inc $9.65 USD +0.015
Becton Dickinson and Co $140.18 USD -0.25
Bio-Techne Corp $94.00 USD +0.34
Enzo Biochem Inc $4.59 USD -0.095
Sigma-Aldrich Corp $136.48 USD -0.02
View Industry Companies
 

Industry Analysis

ABC

Industry Average

Valuation ABC Industry Range
Price/Earnings 24.0x
Price/Sales 6.4x
Price/Book 4.5x
Price/Cash Flow 24.1x
TEV/Sales 6.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABCAM PLC, please visit www.abcam.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.